Comparison between or =60 Gy Once-Daily Thoracic Irradiation for Patients with Limited-stage Smallcell Lung Cancer
Journal of Lung Cancer
;
: 109-112, 2004.
Artigo
em Coreano
| WPRIM
| ID: wpr-65608
ABSTRACT
PURPOSE:
To review the treatment outcomes of patients with limited-stage small-cell lung cancer (LS-SCLC) receiving daily thoracic irradiation (RT) to > or = 60 Gy. Materials and M ethods The records of patients treated with RT for LS-SCLC between 1990 and 2002 at Pusan National University Hospital were retrospectively reviewed. Fifty-six patients were identified who had received once-daily 1.8~2 Gy fractions from 40 Gy to 63 Gy. All patients received sequential chemotherapy and then RT. These patients were arbitrary divided two groups according to thoracic radiation dose, or =60 Gy. The time to death was assessed using actuarial method.RESULTS:
Two- and 5-year overall survival rates for or =60 Gy group was 32% and 41% and 14% and 21%, respectively (p=1.6). Median overall survival for or =60 Gy group was 17 and 20 months, respectively. Two case of acute Grade 3 esophagitis and one case of acute Grade 4 pneumonitis developed in > or =60 Gy group. The first relapse sites of chest for or =60 Gy group were 9/15 (60%) and 3/8 (38%), respectively (p=0.4).CONCLUSION:
> or =60 Gy once-daily thoracic radiotherapy was generally well tolerated and moderately improves local control compared to <60 Gy in patients with LS_ SCLC who are treated with combination chemotherapy
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Pneumonia
/
Radioterapia
/
Recidiva
/
Tórax
/
Taxa de Sobrevida
/
Estudos Retrospectivos
/
Tratamento Farmacológico
/
Quimioterapia Combinada
/
Esofagite
/
Quimiorradioterapia
Tipo de estudo:
Estudo observacional
Limite:
Humanos
Idioma:
Coreano
Revista:
Journal of Lung Cancer
Ano de publicação:
2004
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS